Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 9/20 | 0.71 |
| ▸ | FGFR1 | P11362 | 8/20 | 0.71 |
| ▸ | SRC | P12931 | 8/20 | 0.71 |
| ▸ | MET | P08581 | 7/20 | 0.71 |
| ▸ | PDGFRB | P09619 | 7/20 | 0.71 |
| ▸ | LCK | P06239 | 4/20 | 0.71 |
| ▸ | YES1 | P07947 | 4/20 | 0.71 |
| ▸ | CDK2 | P24941 | 2/20 | 0.71 |
| ▸ | PTK2B | Q14289 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.71 |
| ▸ | EGFR | P00533 | 2/20 | 0.71 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.71 |
| ▸ | PLK4 | O00444 | 1/20 | 0.71 |
| ▸ | RIOK3 | O14730 | 1/20 | 0.71 |
| ▸ | CASK | O14936 | 1/20 | 0.71 |
| ▸ | GAK | O14976 | 1/20 | 0.71 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.71 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL145626 | 0.90 | KDR (0.71) | KDRFGFR1SRCMETPDGFRB | |
| SCHEMBL7122426 | 0.90 | KDR (0.69) | KDRFGFR1SRCMETPDGFRB | |
| SCHEMBL144160 | 0.90 | KDR (0.73) | KDRFGFR1SRCMETPDGFRB | |
| SCHEMBL144899 | 0.89 | KDR (0.73) | KDRFGFR1SRCMETPDGFRB | |
| SCHEMBL143738 | 0.89 | KDR (0.69) | KDRFGFR1SRCMETPDGFRB | |
| SCHEMBL143151 | 0.88 | KDR (0.72) | KDRFGFR1SRCMETPDGFRB | |
| SCHEMBL144687 | 0.88 | KDR (0.66) | KDRFGFR1SRCMETPDGFRB | |
| SCHEMBL145803 | 0.88 | KDR (0.63) | KDRFGFR1SRCMETPDGFRB | |
| SCHEMBL144198 | 0.88 | KDR (0.63) | KDRFGFR1SRCMETPDGFRB | |
| SCHEMBL140673 | 0.88 | KDR (0.77) | KDRFGFR1SRCMETPDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11571475-B1 | Anti-CD70 and BCR-ABL inhibitor combination therapy | UNIVERSITY OF BERN (CH) | 2023-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11571475-B1 | Anti-CD70 and BCR-ABL inhibitor combination therapy | ABL1, BCR, ZAP70 | KDR 694/4885FGFR1 1172/4885SRC 69/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.